Exploration of Changes in Health-Related Quality of Life after 3 Months of Vagus Nerve Stimulation

Epilepsy and Behavior

Volumn 2, Issue 5, 2001, Pages 460-465

  Cramer, Joyce A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Health related quality of life; Quality of Life in Epilepsy 10 (QOLIE 10); Vagus nerve stimulation

Indexed keywords

EID: 0000919342     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0248     Document Type: Article

References (16)

1. Hermann B P, Whitman S. Behavioral and personality correlates of epilepsy: a review, methodological critique, and conceptual model. Psychol Bull. 95:1984;451-497.
2. Trimble M R, Dodson W E. Epilepsy and quality of life. 1994;Raven Press, New York.
3. Jacoby A. Epilepsy and the quality of everyday life: findings from a study of people with well-controlled epilepsy. Soc Sci Med. 34:1992;657-666.
4. Fisher R S, Vickery B G, Gibson P, Hermann B, Penovich P, Scherer A, Walker S. The impact of epilepsy from the patient's perspective: II. Views about therapy and health care. Epilepsy Res. 41:2000;53-61.
5. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. 38:1997;233-236.
6. Cramer J A, Arrigo C, Van Hammee G, Gauer L J, Cereghino J J. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia. 41:2000;868-874.
7. Cramer J A, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia. 37:1996;577-582.
8. Cramer J A, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 39:1998;81-88.
9. Cramer J A, Arrigo C, Van Hammee G, Bromfield E B. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res. 41:2000;29-38.
10. Dodrill C B, Morris G L. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2:2001;46-53.
11. Bruni J. Outcome evaluation of gabapentin as add-on therapy for partial seizures. Can J Neurol Sci. 25:1998;134-140.
12. McLean M J, Morrell M J, Willmore L J. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia. 40:1999;965-972.
13. Sen A. Inequality reexamined. 1992;Harvard Univ Press, Cambridge. p. 55.
14. Wiebe S, Eliasziw M, Matijevic S. Changes in quality of life in epilepsy: how large must they be to be real? Epilepsia. 42:2001;113-118.
15. De Amici D, Klersy C, Ramajoli F, Brustia L, Politi P. Impact of the Hawthorne effect in a longitudinal clinical trial: the case of anesthesia. Control Clin Trials. 21:2000;103-114.
16. Rush A J, George M S, Sackeim H A. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 47:2000;273-275.